Pulse wave velocity assessment of arterial stiffness can predict cardiovascular disease and identify subclinical organ damage in patients with metabolic syndrome and hypertension.
Is arterial stiffness assessment by pulse wave velocity a useful clinical tool in patients with metabolic syndrome?
Pulse wave velocity is a useful tool for assessing arterial stiffness and subclinical organ damage in patients with metabolic syndrome.
Metabolic syndrome (MS) is not a single disease but a cluster of metabolic disorders associated with increased risk for development of diabetes mellitus and its complications. Currently, the definition of MS published in 2009 is widely used, but there are more versions of the diagnostic criteria, making it difficult to conduct scientific discourse in this area. Increased arterial stiffness (AS) can predict the development of cardiovascular disease both in the general population and in patients with MS. Pulse wave velocity (PWV), as a standard method to assess AS, may point out subclinical organ damage in patients with hypertension. The decrease in PWV level during antihypertensive therapy can identify a group of patients with better outcomes independently of their reduction in blood pressure. The adverse effect of metabolic disturbances on arterial function can be offset by an adequate program of exercises, which includes mainly aerobic physical training. Non-insulin-based insulin resistance index can predict AS due to a strong positive correlation with PWV. The purpose of this paper is to present the results of the review of the literature concerning the relationship between MS and its components, and AS assessed by PWV, including clinical usefulness of PWV measurement in patients with MS and its components.
Starzak et al. (2022) conducted a review in Metabolic syndrome. Pulse wave velocity (PWV) was evaluated. Pulse wave velocity assessment of arterial stiffness can predict cardiovascular disease and identify subclinical organ damage in patients with metabolic syndrome and hypertension.